APG Asset Management N.V. purchased a new position in shares of PerkinElmer, Inc. (NYSE:PKI) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 32,000 shares of the medical research company’s stock, valued at approximately $2,207,000.

Several other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in shares of PerkinElmer by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 10,886,642 shares of the medical research company’s stock worth $741,816,000 after acquiring an additional 273,975 shares during the period. Janus Henderson Group PLC bought a new position in shares of PerkinElmer during the 2nd quarter worth $436,483,000. BlackRock Inc. grew its stake in shares of PerkinElmer by 2.4% during the 2nd quarter. BlackRock Inc. now owns 5,929,277 shares of the medical research company’s stock worth $404,022,000 after acquiring an additional 141,650 shares during the period. Pictet Asset Management Ltd. grew its stake in shares of PerkinElmer by 2.1% during the 2nd quarter. Pictet Asset Management Ltd. now owns 3,433,659 shares of the medical research company’s stock worth $216,526,000 after acquiring an additional 71,540 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in shares of PerkinElmer by 15.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 891,832 shares of the medical research company’s stock worth $51,778,000 after acquiring an additional 118,995 shares during the period. Institutional investors own 91.38% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by Watch List News and is the property of of Watch List News. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The correct version of this news story can be read at https://www.watchlistnews.com/apg-asset-management-n-v-purchases-new-position-in-perkinelmer-inc-pki/1687453.html.

PerkinElmer, Inc. (NYSE:PKI) opened at $71.13 on Wednesday. PerkinElmer, Inc. has a 12 month low of $45.35 and a 12 month high of $73.05. The company has a quick ratio of 2.09, a current ratio of 2.59 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $7,775.64, a PE ratio of 25.38, a price-to-earnings-growth ratio of 2.02 and a beta of 0.77.

The business also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Friday, January 19th will be paid a $0.07 dividend. The ex-dividend date is Thursday, January 18th. This represents a $0.28 annualized dividend and a yield of 0.39%. PerkinElmer’s dividend payout ratio is currently 7.78%.

Several research firms have recently weighed in on PKI. Morgan Stanley increased their price target on PerkinElmer from $77.00 to $78.00 and gave the stock an “overweight” rating in a research note on Friday, November 3rd. Citigroup Inc. reiterated a “buy” rating and set a $80.00 price target (up previously from $74.00) on shares of PerkinElmer in a research note on Tuesday, September 26th. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $67.00 price target on shares of PerkinElmer in a research note on Tuesday, September 26th. Zacks Investment Research upgraded PerkinElmer from a “hold” rating to a “buy” rating and set a $74.00 price target for the company in a research note on Tuesday, August 1st. Finally, Wells Fargo & Company began coverage on PerkinElmer in a research note on Thursday, July 13th. They set a “market perform” rating and a $72.00 price target for the company. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $68.64.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.